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Abstract
Objective: Despite an increase in the proportion of women who access antenatal care, mother-to-child transmission of
syphilis continues to be a consequence of undiagnosed, untreated, or inadequately treated maternal syphilis. We reviewed
evidence on the optimal timing of antenatal interventions to prevent mother-to-child transmission of syphilis and its
associated adverse outcomes.
Design: Systematic review and meta-analysis of published literature. English-language articles were included if they (1)
reported the gestational age at which the mother was screened or tested for syphilis; (2) reported on pregnancy outcome.
No publication date limits were set.
Results: We identified a total of 1,199 publications, of which 84 were selected for further review and five were included. All
showed a lower prevalence of any adverse outcome among women who received an intervention (to include screening and
treatment) in the first and second trimesters of pregnancy compared to the third trimester. The overall odds ratio for any
adverse outcome was 2.24 (95% CI 1.28, 3.93). All sub-analyses by type of outcome presented important heterogeneity
between studies, except for those studies reporting an infected infant (odds ratio 2.92, 95% CI 0.66, 12.87; I2 = 48.2%,
p = 0.165).
Conclusions: Our review has shown that the timing of antenatal care interventions makes a significant difference in the risk
of having an adverse outcome due to syphilis. Women who sought care in the first two trimesters of their pregnancy, and
received the appropriate intervention, were more likely to have a healthy infant, compared to women screened and treated
in the third trimester. Encouraging ALL pregnant women to seek care in the first two trimesters of their pregnancy should
be a priority for health programmes. For interventions to be effective within these health programmes, health systems and
community engagement programmes need to be strengthened to enable pregnant women to seek antenatal care early.
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Introduction
Mother-to-child transmission of syphilis is a consequence of
undiagnosed, untreated, or inadequately treated maternal syphilis,
and can result in a number of adverse pregnancy outcomes
(APOs): late foetal loss, stillbirth, low birth weight, neonatal death,
or an infant with reactive serology and clinical symptoms and signs
(classically called ‘‘congenital syphilis’’) [1]. The likelihood of
transmission (and hence the risk of adverse outcome) will vary
according to both the stage of syphilis infection in the mother
(primary, secondary or latent) [2], and the timing of any
intervention delivered during the pregnancy [3,4].
It has been estimated that untreated syphilis in pregnancy can
directly cause adverse outcomes in around 50% of cases [5]. In
comparison, HIV, if untreated, will result in in-utero transmission
around 20% of the time [6], with additional transmission at the
time of delivery or during breast-feeding [7,8]. The extremely high
rate of adverse outcomes seen in syphilis is probably due to direct
damage caused by the spirochete (Treponema Pallidum) to both the
placenta (microvascular proliferation and inflammation), and the
umbilical cord – both of which will compromise foetal growth and
viability [9].
WHO estimates that 1.3 million pregnant women annually have
active syphilis infection, resulting in a substantial burden of
preventable morbidity and mortality including over 200,000
stillbirths and foetal losses and over 90,000 neonatal deaths [10].
A recent systematic review of interventions to screen for syphilis
among pregnant women concluded that a package of [feasible and
cost-effective] interventions delivered through antenatal care
services could ‘‘reduce the syphilis-attributable incidence of
stillbirth and perinatal death by 50%’’ [11]. The intervention
package included uptake of early antenatal care, decentralisation
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of interventions, improved clinical management, and health
systems strengthening.
Access to antenatal care is one of the major achievements of
maternal and child health programmes in recent years. An agreed
indicator of progress towards the Millennium Development Goals
(Goal 5– reproductive and maternal health), antenatal care
coverage has seen marked improvement in low- and middle-
income settings. The percentage of women who attend for care at
least once during pregnancy has risen from 64% in 1990 to 81% in
2009 [12]. However, despite an increase in the proportion of
women who access antenatal care, we still know very little about
the quality of the care they receive. Moreover, we have scant
information on whether pregnant women are seeking care early
enough in pregnancy for antenatal interventions to have an
impact, or, indeed, what is the optimal timing for many of the
interventions recommended during antenatal care. The purpose of
this review is to look at the evidence on the optimal timing of
syphilis screening and treatment to prevent mother-to-child
transmission of syphilis and its associated adverse outcomes.
Methods
This systematic review adhered to the PRISMA guidelines for
reporting of systematic reviews [13] (Text S1: PRISMA checklist).
Search Strategy
Our study question was formulated as ‘‘Is there an increased
risk of adverse outcomes associated with screening and treating
women for syphilis in the third trimester compared with screening
and treating in the first or second trimester?’’ We searched
PubMed for articles with no date limitations using a search
strategy combining the MESH terms: ‘‘syphilis’’ and ‘‘screening’’
and ‘‘pregnancy’’. When relevant articles were located and
reviewed, we searched their reference lists for additional articles.
We also sought expert opinion on any additional articles which
may fit the search criteria for the review.
Articles were included in the systematic review if they were
publications in peer-reviewed journals, or conference papers of
primary research. Full text articles were assessed and only included
if they contained the following information: (1) they reported the
gestational age at which the mother was screened or tested for
syphilis; (2) they reported on pregnancy outcome. We considered
experimental and observational designs, including prospective and
retrospective cohort as well as cross-sectional studies. That the
search was limited to published articles was designed to avoid poor
quality studies. However, this might have led to some publication
bias. Abstract and initial full-text reviews were undertaken by one
reviewer (GG). Two authors (GG and SH) then reviewed full text
articles and reached consensus decisions on which articles should
be included in the systematic review and meta-analysis.
Data Analysis
Data were prepared and analysed using Stata/SE 11.0 (STATA
Corporation, TX, USA). Information extracted included study
characteristics such as geographical location, sample size, syphilis
testing, treatment available, and outcome prevalence. We calcu-
lated the crude prevalence estimate and standard error for two
groups: women being tested or treated before the third trimester
(i.e. at any point of the pregnancy until week 28) and those being
tested or treated during the third trimester (from week 28 until
delivery) [14,15]. Effect sizes were summarized as odds ratios
(ORs) and associated 95% confidence intervals (95%CI). An OR
greater than one suggests that access to ANC during the third
trimester increases the risk of having an adverse pregnancy
outcome. We performed a random effect meta-analysis to obtain
pooled estimates of ORs. Both I2 statistic and p values were used
to assess heterogeneity between studies. We explored possible
sources of heterogeneity due to characteristics of both recording of
the outcome and treatment in sub-group meta-analyses [14,15].
Results
The initial search, conducted in November 2010, identified
1,190 articles. This search was then updated in May 2011
identifying a total of 1,199 publications. After excluding articles on
the basis of not meeting the inclusion criteria noted above, the full
abstracts of 538 papers were read by one reviewer and four articles
were excluded because the full text was in Chinese, Hebrew,
Russian, or Slovak [16,17,18,19]. Of those 82 articles selected for
full-text review, an additional 77 were excluded (on the decision of
two reviewers) since they did not meet the inclusion criteria.
Finally, five articles [20,21,22,23,24] were included (see Figure 1)
and data extracted from full text articles are shown in Table 1.
Of the five full-text articles included in the meta-analysis, three
studies were located in the Americas (two in the United States of
America [23,24]and one in Guyana [20]), one in Asia (China
[22]), and one in Africa (Tanzania [21]). Overall, almost 3,000
pregnancies were followed and outcomes recorded (n = 2,939), and
studies were conducted almost 60 years apart (papers published
from 1951 to 2010). Ingraham et al and Alexander et al reported
events of ‘‘congenital syphilis’’ only, defined as a live born child
presenting signs and symptoms of syphilis infection [23,24].
Watson-Jones et al data were included for all adverse outcomes
including ‘‘prematurity’’ (as defined by an ultrasound/Dubovitz
scale) and ‘‘stillbirth’’ [21]. Carles et al and Zhu et al combined
the results into a single ‘‘all adverse outcomes’’ group [20][22].
The definitions of cut-off points for the two groups (treatment
during the first and second trimester and during the third
trimester) varied across the studies. One study took a cut-off point
of 28 weeks to compare women receiving care before or after this
date [22]. Two studies compared women who received their first
antenatal care visit and treatment before or during week 31, with
women who visited/were treated after week 31 [23,24], whilst for
another study the cut-off point was week 30 [21]. The fifth study
compared women receiving screening and treatment as late as 30
days before delivery with those treated earlier in their pregnancy
[20].
Prevalence of adverse outcomes is reported in Figure 2 for all
studies as according to the defined subgroups based on gestational
age at treatment/first antenatal care visit. Overall all studies
showed a lower prevalence of any adverse outcome among women
who received an intervention (including syphilis screening and
treatment) in the first or second trimesters of pregnancy. Among
those women who did not receive syphilis screening and treatment
until the third trimester, we observed a large prevalence range
depending on the outcome reported – from 2% for ‘‘classical’’
congenital syphilis (an infected infant) to 68% for any reported
adverse outcome.
The odds ratio for any adverse outcomes from being screened
and treated in the third trimester compared to the first and second
trimesters was 2.24 (95% CI 1.28, 3.93) – see Figure 3. However,
an important amount of heterogeneity was observed (I2 = 71.0%,
p= 0.008). To explore the sources of heterogeneity, Figure 4 shows
the results of the sensitivity analyses. The OR for studies that
reported only ‘‘congenital syphilis’’ (infected infant) events could
be pooled to be 2.92 (95% CI 0.66, 12.87; I2 = 48.2%, p= 0.165).
All other sub-analyses presented important heterogeneity between
studies. However, there was a strong indication of an increased risk
Early ANC for Preventing Congenital Syphilis
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Figure 1. Flowchart of study selection. * includes: policy commentaries, policy analysis, clinical guidelines, best practice, commentaries/news/
editorials, service audit and review, reporting analysis, patient satisfaction study, HIV+ samples, healthcare professional attitudes and practices
surveys.
doi:10.1371/journal.pone.0056713.g001
Table 1. Study characteristics.
Reference Country Study type
Sample
size Syphilis diagnosis, treatment regime, and mean gestational age at treatment
Ingraham 1951 [24] USA Treatment trial 663 Kahn test; aqueous penicillin by frequent injection (2.4 MU); 24 weeks*.
Alexander 1999 [23] USA Prospective cohort 340 RPR or VDRL with TPHA confirmation; single dose of benzathine penicillin G (2.4 MU)
intramuscular; 32 weeks.
Watson-Jones 2002
[21]
Tanzania Prospective cohort 382 RPR with confirmation TPHA or FTA-Abs; single dose of benzathine penicillin G (2.4 MU)
intramuscular; mean gestational age at treatment: 25.3 weeks (SD 5.8; range 6.4–40.9).
Carles 2008 [20] Guyana Retrospective cohort 85 VDRL or TPHA with confirmation FTA IgM; two or three doses benzathine penicillin G
(2.4 MU) intramuscular; 24 weeks (range 10–40).
Zhu 2010 [22] China Prospective cohort 1,469 RPR or TPPA with confirmation TPHA; for primary, secondary, early latent syphilis,
benzathine penicillin G (4.8 MU) intramuscularly in two doses (9.6 MU in total) weekly.
For late latent syphilis, benzathine penicillin G (2.4 MU) intramuscularly in three doses
(7.2 MU in total) weekly; 25 weeks*.
RPR, rapid plasma regain test; VDRL, venereal disease research laboratory test; TPHA, Treponema pallidum haemagglutination testing; TPPA, Treponema pallidum particle
agglutination assay; FTA-Abs/FTA IgM, fluorescent treponemal antibody absorbed test; MU, million units; SD: standard deviation; n, number of patients presenting the
outcome. All adverse pregnancy outcomes (APOs) included: low birth weight, stillbirth, and preterm birth for Watson-Jones 2002; low birth weight, preterm birth,
intrauterine death for Carles 2008; congenital syphilis, foetal death, and neonatal death for Zhu 2010.
*Estimate value from reported distribution.
doi:10.1371/journal.pone.0056713.t001
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of adverse outcomes if women delay ANC care independently of
treatment available or description of the intervention: the pooled
ORs ranged from 2.42 (95% CI 1.27, 4.59; I2 = 78.3%, p= 0.003)
for studies reporting treatment with benzathine penicillin G only
compared to those reporting treatment with aqueous penicillin to
2.70 (95% CI 1.13, 6.44; I2 = 78.3%, p= 0.003) for studies that
reported on gestational age at treatment only as opposed to
gestational age at treatment or first ANC.
Discussion
Syphilis continues to exert a high burden of disease globally
[10], and in several parts of the world rates of congenital syphilis
are rising [25,26]. The extremely high rates of adverse outcomes of
pregnancy associated with in-utero transmission can be substan-
tially reduced through relatively simple and cost-effective inter-
ventions which are feasible to administer in most settings [27],
include serological or whole blood screening, and treatment with
penicillin for women (and their partners) found to be seropositive.
Recently, WHO has called for the global elimination of mother-to-
child transmission of syphilis, through commitment to and
implementation of four strategic pillars – advocacy and political
commitment; early access to maternal and neonatal health care;
screening all pregnant women; surveillance, monitoring and
evaluation [28]. Pillar 2 of the WHO global strategy explicitly
mentions a goal of ‘‘increasing the percentage of pregnant women
attending….facilities early in pregnancy’’ [28]. However, to date,
there has been no review of the effectiveness of early interventions
to prevent mother to child transmission of syphilis.
This review represents the first systematic evaluation of the
impact of screening and treating women early in pregnancy
compared to later in pregnancy. We have defined ‘‘early’’ in its
broadest terms – the first and second trimesters (i.e. up to and
including week 27 of the pregnancy). This was mainly done for
pragmatic reasons – antenatal care is often not sought till at least
the second trimester in many settings [29], therefore we assumed a
Figure 2. Prevalence of adverse pregnancy outcomes among all syphilis-positive women and by subgroup (tested or treated before
the third trimester or during the third trimester). ANC, ante-natal care. All adverse pregnancy outcomes (APOs) included: low birth weight,
stillbirth, and preterm birth for Watson-Jones 2002; low birth weight, preterm birth, intrauterine death for Carles 2008; congenital syphilis, foetal
death, and neonatal death for Zhu 2010.
doi:10.1371/journal.pone.0056713.g002
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priori that there would be insufficient data to allow us to analyse the
impact of screening and treatment in the first trimester alone.
We identified five studies which compared women seeking and
receiving interventions (screening and treatment for syphilis) in the
first and second trimesters (reference group) compared to those
women not seen until the third trimester [20,21,22,23,24]. Overall
prevalence of any adverse pregnancy outcomes was higher among
women seen in the third trimester compared to the reference
group for all studies – resulting in an odds ratio of 2.24 (for adverse
outcomes among women seen later in their pregnancies). There
was an important heterogeneity observed between studies, and
results might have been affected by individual study designs.
According to the results of our meta-analyses by sub-groups, the
main characteristic that helped explain the heterogeneity observed
was the type of outcome reported.
Screening and treatment earlier in the pregnancy had an
impact, in general,on the risk of all adverse outcomes (OR=2.24
(95% CI 1.28, 3.93)), and in particular, on the risk of ‘congenital
syphilis’ (i.e. an infant with evidence of infection; OR=2.92 (95%
CI 0.66, 12.87)). However, only the studies reporting on congenital
syphilis events [23,24] were statistically similar and their estimates
could be confidently pooled. Among those studies reporting on all
adverse outcomes, there were some methodological differences.
For instance, Watson-Jones et al [21] included low birth weight,
stillbirth, and preterm birth in their definition of all adverse
outcomes, and presented detailed data on individual pregnancy
outcomes. Zhu et al [22] included congenital syphilis (i.e. an
infected infant), foetal death, and neonatal death in their
definition, and included mothers with primary, secondary, and
tertiary syphilis in their analysis. Both of these studies might have
underestimated the rate of adverse outcomes. Meanwhile, Carles
et al [20] looked at low birth weight, preterm birth, and
intrauterine death in a population accessing services very late
during the pregnancy or at birth.
Overall, there was an increased risk of prematurity in mothers
presenting late to ANC, with an odds ratio of 2.09 (95% CI 1.09–
4.00). For stillbirth, we found an odds ratio of 0.71 (95% CI 0.21–
2.48; not significant), probably due to the small number of events
observed (n = 15 stillbirths overall, only three in women presenting
to ANC during the third trimester).
As noted, antenatal care is now accessed at least once in
pregnancy by a majority of women. This is a significant public
health achievement and a reflection of the highest level of global
commitment to ensure that all pregnant women can access the
antenatal care they need [30], which has helped to mobilise
resource allocation in this area. However, the global goals and
commitments for antenatal care do not, at present, include a target
for ensuring that women seek care early enough in pregnancy for
interventions to be most effective.
We still know little about ‘‘what works’’ in terms of successfully
enabling women to seek and receive antenatal care early in their
pregnancies. As mentioned, women face numerous obstacles to
early antenatal care, including cultural barriers [31], economic
barriers [31,32], and misconceptions about the perceived and
actual benefits of early antenatal care [33]. We have little
empirical or trial evidence on how to increase early antenatal
Figure 3. Odds ratios – adverse outcomes of women tested or treated during the third trimester compared to those women tested
or treated before the third trimester (reference). Ref, reference; wks, weeks; d, days.
doi:10.1371/journal.pone.0056713.g003
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care attendance. A non-randomised controlled trial conducted in
Zambia in the late 1980s showed that a multi-pronged interven-
tion including behaviour change messages aimed at whole
communities as well as specific groups in those communities had
the effect of increasing the percentage of pregnant women who
sought ANC in the first trimester from 9.4% (68/723) to 42.5%
(194/457) [34]. Components of the successful intervention
included provision of health information about the importance
of early antenatal care to groups identified as sexually active (for
example, women at family planning clinics, men and women at
out-patient clinics), and to elderly community members who have
a specific role as community leaders and influencers. Health
education messages were developed in collaboration with local
communities, and were given repeatedly. However, additional
high quality (for example, randomised controlled trial) evidence is
currently lacking in this area.
Our review has clearly shown that the timing of antenatal care
interventions to prevent adverse outcomes due to syphilis makes a
significant difference in outcome rates. Women who sought care in
the first two trimesters of their pregnancy, and received the
appropriate intervention, were more likely to have a healthy
infant, than those who waited until the third trimester before
seeking care. Such findings carry important implications for
antenatal care programmes, and whether or not similar findings
are observed with other antenatal care interventions (such as
preventing mother to child transmission of HIV) needs further
exploration.
Encouraging ALL pregnant women to seek care in the first two
trimesters of their pregnancy to avoid preventable adverse
outcomes should be a priority for health programmes. This is
likely to be achievable, in part, with strengthening of health
systems so that health workers are able to provide high quality
comprehensive antenatal care for all women. Screening for syphilis
and HIV during the first ANC visit is recommended. However,
the timing of this visit in addition to whether these tests were
performed and treatment received should be seen as indicators of
high quality antenatal care. Early access to ANC will also be
enhanced by community engagement programmes that work with
women, their families and their communities to enable pregnant
women to seek antenatal care as early as possible for interventions
to be effective – the mechanisms and methods by which to achieve
this deserve further attention.
Figure 4. Sub-group meta-analyses. Ref, reference; wks, weeks; d, days. All adverse pregnancy outcomes (APOs) included: low birth weight,
stillbirth, and preterm birth for Watson-Jones 2002; low birth weight, preterm birth, intrauterine death for Carles 2008; congenital syphilis, foetal
death, and neonatal death for Zhu 2010.
doi:10.1371/journal.pone.0056713.g004
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